ECU
ACAD icon

Eisler Capital (US)’s Acadia Pharmaceuticals ACAD Stock Holding History

Eisler Capital (US)’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50,340
Closed -$818K – 153
2024
Q2 		$818K Buy
50,340
+10,992
+28% +$179K 0.01% 208
2024
Q1 		$728K Buy
+39,348
New +$728K 0.02% 92